The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ...

NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel ...

Voigt is the youngest billionaire heir of WEG cofounder Werner Ricardo Voigt and owns a 3.1% stake in the company, like her sister. She is currently studying psychology at university. After Forbes ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

According to Forbes, nearly 75% of the world’s dollar billionaires are between 50 and 79 years old, and just 12% are under 50 ...

With counterfeit drugs making up 30% of global sales, regulators are tightening serialisation and labelling rules to secure ...

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer ...

Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to EUR 6.2 billion, 23.2% of group net salesCompany prepares ...

Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Nearly three-quarters of the world’s billionaires are between the ages of 50 and 79. Just 12% are under 50. The rarest of all ...